10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,588,741 | +1358.7% | 499,121 | +1874.7% | 0.31% | +1547.4% |
Q2 2023 | $1,411,412 | +61.0% | 25,276 | +60.9% | 0.02% | +26.7% |
Q1 2023 | $876,461 | +137.6% | 15,710 | +55.2% | 0.02% | +114.3% |
Q4 2022 | $368,846 | -47.6% | 10,122 | -59.0% | 0.01% | -41.7% |
Q3 2022 | $704,000 | -97.3% | 24,702 | -95.6% | 0.01% | -97.4% |
Q2 2022 | $25,679,000 | -54.6% | 567,487 | -23.7% | 0.46% | -12.4% |
Q1 2022 | $56,579,000 | -50.4% | 743,781 | -3.0% | 0.52% | -19.5% |
Q4 2021 | $114,167,000 | +0.8% | 766,428 | -1.5% | 0.65% | +10.7% |
Q3 2021 | $113,224,000 | -25.6% | 777,747 | +0.1% | 0.59% | -21.4% |
Q2 2021 | $152,118,000 | +7.5% | 776,825 | -0.6% | 0.75% | -2.1% |
Q1 2021 | $141,476,000 | +25.4% | 781,635 | -1.9% | 0.76% | +36.2% |
Q4 2020 | $112,806,000 | +31.4% | 796,655 | +15.7% | 0.56% | +5.9% |
Q3 2020 | $85,856,000 | +85.2% | 688,611 | +32.6% | 0.53% | +45.7% |
Q2 2020 | $46,367,000 | – | 519,168 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |